Key result
Adjunctive mobile HRV biofeedback substantially reduces depression severity at 5 weeks versus standard treatment.
Why the study?
Heart rate variability biofeedback benefits depressive symptoms and autonomic functioning, but its efficacy during inpatient psychiatric rehabilitation receiving highly comprehensive treatments had not been evaluated.
Does adjunctive heart rate variability biofeedback improve depressive symptoms and autonomic functioning in inpatients undergoing psychiatric rehabilitation?
RCT (n=92)
Open-label
Randomly assigned
No
Does adjunctive heart rate variability biofeedback improve depressive symptoms and autonomic functioning in inpatients undergoing psychiatric rehabilitation?
Standardized Mean Difference: 0.79
Absolute Event Rate: 9.18% vs 12.5%
p-value: p=0.042
Adjunctive heart rate variability biofeedback during inpatient psychiatric rehabilitation facilitates short-term recovery of depressive symptoms and enhances autonomic functioning, though long-term benefits may require continued practice.
May support short-term adjunctive HRVBF for inpatient depression; leaves open durability and need for larger trials.
OBJECTIVE: New treatment options for depression are warranted, due to high recurrence rates. Recent research indicates benefits of heart rate variability biofeedback (HRVBF) on symptom recovery and autonomic functioning in depressed individuals. Slow-paced breathing-induced amplification of vagus nerve activity is the main element of HRVBF. Thus, the latter represents a safe and non-invasive complementary depression treatment. However, its efficacy in patients undergoing inpatient psychiatric rehabilitation receiving highly comprehensive treatments has not been evaluated. METHODS: Ninety-two inpatients were randomly assigned to an intervention group (IG) or control group (CG). While the latter received the standard treatment only, adjunctive HRVBF was provided to the IG over 5 weeks. Depression severity and heart rate variability (HRV) were assessed before (pre) and after 5 weeks (post). Moreover, 1-year follow-up depression scores were available for 30 participants. RESULTS: = 0.48). CONCLUSION: HRVBF as adjuvant therapy during inpatient psychiatric rehabilitation facilitated depression recovery. Additionally, amplified LF-HRV as well as cardiorespiratory coherence at rest and a decrease in resting breathing frequency was observed in the HRVBF group. These findings emphasize HRVBF's value as complementary therapy regardless of concurrent treatments. Moreover, these incremental benefits could serve as resource even after the actual training period. However, the additional antidepressant gains vanish during the long-term follow-up, indicating the need for more intense training or regular practice afterward, respectively. Thus, future studies are warranted to examine how the initial benefits of HRVBF during inpatient psychiatric rehabilitation can be preserved post discharge.
No takes yet. Share an insight, caveat, or question.
Tatschl et al. (2020) conducted an RCT in Depression in psychiatric rehabilitation (n=92). Mobile HRV Biofeedback vs. Standard psychiatric rehabilitation treatment was evaluated on Depression severity (BDI-II score) at 5 weeks (d = 0.79, p=0.042). Adjunctive mobile heart rate variability biofeedback during inpatient psychiatric rehabilitation significantly reduced depression severity at 5 weeks compared to standard treatment alone (d = 0.79).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: